HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jürgen Wolf Selected Research
Jürgen Wolf Research Topics
Disease
53
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 01/2008
50
Neoplasms (Cancer)
01/2024 - 01/2002
40
Lung Neoplasms (Lung Cancer)
04/2024 - 01/2008
9
Disease Progression
03/2024 - 12/2011
8
Adenocarcinoma of Lung
01/2019 - 12/2010
6
Diarrhea
11/2023 - 01/2011
6
Neoplasm Metastasis (Metastasis)
01/2023 - 03/2010
5
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2024 - 02/2014
4
Exanthema (Rash)
10/2023 - 01/2011
3
Nausea
11/2023 - 03/2011
3
Melanoma (Melanoma, Malignant)
10/2023 - 08/2015
3
Hypertension (High Blood Pressure)
10/2022 - 03/2011
3
Myocardial Infarction
01/2012 - 03/2006
2
Fatigue
01/2023 - 03/2011
2
Adenocarcinoma
01/2023 - 10/2016
2
Brain Neoplasms (Brain Tumor)
01/2021 - 01/2019
2
Multiple Myeloma
01/2018 - 11/2005
2
Sarcoma (Soft Tissue Sarcoma)
02/2017 - 06/2009
2
Small Cell Carcinoma
02/2016 - 02/2015
2
Colorectal Neoplasms (Colorectal Cancer)
08/2015 - 05/2007
2
Infarction (Infarctions)
01/2012 - 04/2010
2
Breast Neoplasms (Breast Cancer)
06/2011 - 01/2011
2
Ventricular Remodeling
09/2008 - 03/2006
2
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2005 - 07/2004
2
Hodgkin Disease (Hodgkin's Disease)
11/2005 - 01/2002
1
Dizziness (Lightheadedness)
01/2024
1
Dysgeusia (Parageusia)
01/2024
1
Paresthesia (Dysesthesia)
01/2024
1
Neuroblastoma
10/2023
1
Dermatitis
10/2023
1
Stevens-Johnson Syndrome (Lyell's Syndrome)
10/2023
1
Febrile Neutropenia
01/2023
1
Neutropenia
01/2023
1
Cough
01/2023
Drug/Important Bio-Agent (IBA)
17
Tyrosine Kinase Inhibitors
IBA
04/2024 - 05/2011
14
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2019 - 01/2008
11
Biomarkers (Surrogate Marker)
IBA
03/2024 - 05/2011
10
ErbB Receptors (EGF Receptor)
IBA
04/2024 - 01/2008
10
Phosphotransferases (Kinase)
IBA
10/2023 - 11/2005
7
Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)
IBA
09/2017 - 12/2010
6
Proteins (Proteins, Gene)
FDA Link
11/2023 - 01/2002
6
Crizotinib
IBA
01/2019 - 09/2014
5
Ligands
IBA
12/2023 - 02/2014
5
selpercatinib
IBA
11/2023 - 01/2020
5
Anaplastic Lymphoma Kinase
IBA
01/2018 - 12/2010
5
Glucose (Dextrose)
FDA Link
Generic
01/2015 - 01/2008
4
DNA (Deoxyribonucleic Acid)
IBA
05/2024 - 09/2012
4
Immune Checkpoint Inhibitors
IBA
12/2023 - 03/2015
4
sotorasib
IBA
11/2023 - 01/2021
4
Thymidine
IBA
01/2015 - 01/2008
3
osimertinib
IBA
12/2021 - 10/2016
3
Pemetrexed (MTA)
FDA Link
03/2021 - 03/2011
3
Everolimus
FDA Link
01/2020 - 11/2009
3
Afatinib
IBA
11/2018 - 09/2012
3
B7-H1 Antigen
IBA
02/2018 - 02/2015
3
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
01/2017 - 11/2012
3
RNA (Ribonucleic Acid)
IBA
02/2015 - 05/2007
3
Dasatinib (BMS 354825)
FDA Link
09/2011 - 06/2009
2
pembrolizumab
IBA
12/2023 - 03/2021
2
Enzymes
IBA
11/2023 - 06/2011
2
trametinib
IBA
10/2023 - 12/2021
2
capmatinib
IBA
01/2023 - 01/2020
2
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
10/2022 - 01/2020
2
Alanine Transaminase (SGPT)
IBA
10/2022 - 01/2020
2
Cisplatin (Platino)
FDA Link
Generic
03/2021 - 11/2016
2
Programmed Cell Death 1 Receptor
IBA
01/2021 - 02/2015
2
Sorafenib (BAY 43-9006)
FDA Link
01/2020 - 09/2011
2
Tyrosine (L-Tyrosine)
FDA Link
01/2019 - 06/2011
2
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2019 - 09/2017
2
Integrins
IBA
11/2018 - 01/2017
2
Vemurafenib
IBA
01/2018 - 08/2015
2
Antigens
IBA
03/2017 - 02/2010
2
Immunoglobulin G (IgG)
IBA
03/2017 - 03/2015
2
Etoposide (VP 16)
FDA Link
Generic
11/2016 - 01/2002
2
Monoclonal Antibodies
IBA
02/2015 - 02/2015
2
vandetanib (ZD6474)
IBA
04/2013 - 03/2011
2
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
12/2011 - 11/2009
2
Gefitinib (Iressa)
FDA Link
06/2011 - 05/2011
2
Aripiprazole (Abilify)
FDA Link
10/2007 - 09/2004
2
Transcription Factors (Transcription Factor)
IBA
11/2005 - 07/2004
2
NF-kappa B (NF-kB)
IBA
11/2005 - 07/2004
2
NF-KappaB Inhibitor alpha
IBA
11/2005 - 07/2004
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
03/2002 - 01/2002
1
repotrectinib
IBA
01/2024
1
epidermal growth factor receptor VIII
IBA
11/2023
1
Protein Kinases (Protein Kinase)
IBA
10/2023
1
Creatine Kinase (Creatine Phosphokinase)
IBA
10/2023
1
naporafenib
IBA
10/2023
1
Lipase (Acid Lipase)
FDA Link
10/2023
1
Docetaxel (Taxotere)
FDA Link
01/2023
1
amivantamab-vmjw
IBA
01/2023
Therapy/Procedure
50
Therapeutics
04/2024 - 01/2002
8
Immunotherapy
03/2024 - 05/2007
7
Drug Therapy (Chemotherapy)
03/2024 - 12/2011
5
Genomic Medicine
01/2024 - 07/2015
4
Palliative Care (Palliative Therapy)
12/2023 - 05/2008
4
Radiotherapy
01/2021 - 01/2002
2
Aftercare (After-Treatment)
10/2016 - 01/2008
1
Precision Medicine
01/2024
1
Chemoradiotherapy
10/2023